baber/WOPTO huggingface dataset:
Patent AT-E173613-T1 (AT)
Inventor: DONG LIANG C
IPC: A61K9/22
Filed: 1994-08-31
Granted: 1998-12-15
Abstract: The present invention is directed to a formulation for the delivery of hydrophobic active agents to a fluid environment of use while avoiding aggregation of the hydrophobic agents in the environment, the formulation comprising a hydrophobic active agent in an amount of 50 wt% (percent by weight) or greater together with polyoxyethylene 40 stearate and a disintegrant. The present invention is also directed to an improvement in a fluid-activated delivery device (10) wherein the delivery device includes a housing (12) defining an internal compartment (14), an active agent formulation (15) in the compartment, exit means (13) in the housing (12) for delivering the active agent formulation (15) from the delivery device, a fluid-activated expandable driving member (16) in the compartment, optionally a partition layer between the active agent formulation (15) and the driving member (16), and optionally a lubricant subcoat (18); wherein the improvement comprises an active agent formulation (15) comprising a hydrophobic active agent in an amount of 50 wt% (percent by weight) or greater together with polyoxyethylene 40 stearate and a disintegrant.
Patent AT-E196062-T1 (AT)
Inventor: BOSTELMANN RUDOLF
IPC: A24C5/47
Filed: 1995-02-28
Granted: 2000-09-15
Abstract: The transport system has a pneumatic feed line, to which the cigarette filters are fed individually from a supply reservoir, via axis parallel reception pockets (2) in a rotary transfer wheel (1). The pockets are indexed past an ejection zone, in which the filter is displaced along its axis by pressurised air, for input to the pneumatic line. The longitudinal movement of the filter in the ejection zone is monitored, with a fault signal supplied when the filter fails to be ejected from the pocket in a given time interval, pref. defined between the entry of the pocket into the ejection zone and the exit of the pocket from the ejection zone.
Patent AT-E194251-T1 (AT)
Inventor: TORAZAWA HIROYASU
IPC: H01L31/12
Filed: 1995-07-27
Granted: 2000-07-15
Abstract: A photosemiconductor relay of the present invention comprises a light-emitting unit for emitting light therefrom, a light-receiving control circuit for providing a predetermined potential difference or more between a first connecting terminal and a second connecting terminal during a light-receiving period and electrically connecting the first and second connecting terminals to each other in response to the non-reception of the light, and a switching circuit for electrically connecting a first output terminal and a second output terminal to each other in response to the reception of the predetermined potential difference or more and restricting a load current flowing between the first and second output terminals to a predetermined value or less. Thus, since a current of a predetermined value or more does not flow into a load circuit connected between the output terminals, the load circuit is prevented from malfunctioning and the switching circuit is promptly turned off. <MATH>
Patent AT-E170082-T1 (AT)
Inventor: BUEHRING HANS-JOERG DR
IPC: A61K39/395
Filed: 1995-11-07
Granted: 1998-09-15
Abstract: The present invention identifies a subset of leukemic cells which express HER-2 protein on their cell surface. The invention features methods for inhibiting the growth of such cells and treating leukemia patients by targeting the HER-2 protein. The HER-2 protein is targeted using different techniques such as using anti-HER-2 agents which inhibit HER-2 protein activity and the growth of cells expressing HER-2, using anti-HER-2 agents which bind to HER-2 protein and kill cells expressing HER-2, and using HER-2 protein binding agents to selectively remove leukemic cells expressing HER-2 from normal hematopoietic cells.
Patent AT-E173759-T1 (AT)
Inventor: TAYLOR ROBERT
IPC: C08H1/06
Filed: 1995-03-16
Granted: 1998-12-15
Abstract: A process for preparing collagen finings is provided. The process comprises providing collagen in the form of fish isinglass which has been freshly prepared or frozen, substantially in the absence of any pre-drying. The isinglass is hydrolysed under conditions to solubilise the collagen. By using the freshly-prepared or frozen isinglass the irreversible changes to the collagen arising from pre-drying of the isinglass are largely avoided.
Patent AT-E180861-T1 (AT)
Inventor: LLAGOSTERA MARCO JUAN C CASTEL
IPC: E04F10/06
Filed: 1995-03-09
Granted: 1999-06-15
Abstract: The roller blind, esp. one of considerable length, has a housing (10) which is open at the front and is fixed at its two ends to a U-shaped component (21) with one branch (21a) longer than the other, while a plate is connected to the upper and lower branches to support the end of the roller axle and at least part of its drive mechanism. The distance between the two arms of the U-shaped component is sufficient to allow the blind roller, complete with the rolled blind, to be fitted between them from the front. The housing is fixed to a vertical wall (46) by brackets (44), and is shaped to receive a front component (30) which closes the housing once the blind is rolled up inside it.
Patent AT-E191156-T1 (AT)
Inventor: MORO FRANCO EUSEBIO
IPC: B01D8/00
Filed: 1995-01-10
Granted: 2000-04-15
Abstract: Cryogenic liquid based filtration of contaminated fluid comprises mixing of the fluid (gas or smoke) with fine water droplets injected into the mixes. The water is blended with the cryogenic liquid to form hail which is evacuated through gravity. Preferred Features: The water is pre-cooled to near freezing point, to reduce the consumption of cryogenic liquid.
Patent AT-E185803-T1 (AT)
Inventor: ANDO AKEMI
IPC: C07D277/10
Filed: 1995-06-07
Granted: 1999-11-15
Abstract: PCT No. PCT/JP95/01127 Sec. 371 Date Nov. 5, 1997 Sec. 102(e) Date Nov. 5, 1997 PCT Filed Jun. 7, 1995 PCT Pub. No. WO96/40659 PCT Pub. Date Dec. 19, 1996Described herein are N-hydroxyurea compounds having the ability to inhibit the 5-lipoxygenase enzyme and having formula (I) and the pharmaceutically acceptable salts thereof. The variables are described herein. These compounds are useful in the treatment or alleviation of inflammatory diseases, allergy and cardiovascular diseases in mammals and as the active ingredient in pharmaceutical compositions for treating such conditions.    <IMAGE>  (I)
Patent AT-E190534-T1 (AT)
Inventor: LEWIS DAVID L
IPC: B23B31/00
Filed: 1995-06-09
Granted: 2000-04-15
Abstract: A collet chuck 1 having a chuck body 3, a collet 11 disposed in the body 3, a nose ring 23 for radially compressing the collet 11, and a locknut 30 for axially moving the nose ring 23 into compressive engagement with the collet 11 is provided with a bearing assembly 45 disposed between the nose ring 23 and the collet 11 which loads compressive forces in a direction which is advantageously parallel to the axis of rotation A of the chuck. Both the locknut 30 and the nose ring 23 include flange portions 27, 43 that confront each other with opposing surfaces 47, 49 that are complementary in shape to the spherical profile of the ball bearings 50 and which traverse a line L parallel to the axis of rotation A of the chuck. The collet chuck 1 further includes O-rings 61, 65 disposed between the nose ring 23 and the locknut 30both in front of and behind the ball bearings 50 for sealing the bearing assembly 45 against dust and debris and retaining lubricant. Finally, the portion of the nose ring 23 which wedgingly engages the collet 11 to compress it inwardly is undercut with a groove 72 in order to enhance the compliance between the nose ring 23 and the collet 11, thus providing a more uniform radial compressive force around the collet 11 which in turn results in improved gripping characteristics.
Patent AT-E173412-T1 (AT)
Inventor: GRIGOROVA BOJIDARA
IPC: B01D53/94
Filed: 1995-06-19
Granted: 1998-12-15
Abstract: A catalyst for use in an oxidation reaction comprises a porous alumina support in the form of pellets or powder, preferably powder. The porous alumina support has captured thereon a complex comprising gold, a transition metal selected from cobalt or manganese, and alumina, the concentration of gold on the support being less than 2 percent by mass of the catalyst, and the atomic ratio of gold to transition metal being in the range 1:10 to 1:200.
Patent AT-E330042-T1 (AT)
Inventor: ROCHE ALLEN DENNIS
IPC: C23C4/18
Filed: 1995-09-25
Granted: 2006-07-15
Abstract: Atomized metal is deposited metal onto a substrate so as to cause at least partial solidification of the deposited metal; further atomized metal is deposited onto the partially solidified deposited metal on the substrate; and the metal deposited onto the partially solidified deposited metal is allowed to fully solidify on the substrate; the cooling of the further deposited metal, and the composition of the metal and/or of a gas used in the atomization of the further atomized metal being tailored such that volumetric contraction on solidification and cooling of the further deposited metal is compensated for, when the deposited metal has been cooled to ambient temperature, by volumetric expansion in a reaction or phase change in the further deposited metal.
Patent AT-E321280-T1 (AT)
Inventor: KOTTEN KLAUS DIPL-ING
IPC: G02B6/28
Filed: 1996-04-12
Granted: 2006-04-15
Abstract: In a circuit arrangement for dispersion compensation in optical transmission systems by means of an optical filter, an optical transverse filter is provided as a negative dispersion filter, and which has a series of directional couplers which respectively follow one another at a spacing of  tau /2 and are operated as splitters. A series of directional couplers are provided which likewise follow one another at a spacing of  tau /2 and are operated as combiners, the second output of each directional coupler of the directional couplers operated as splitters leading in each case to the second input of the respectively corresponding directional coupler operated as a combiner.
Patent AT-E194932-T1 (AT)
Inventor: ROHDE WOLFGANG PROF DR
IPC: B21B13/14
Filed: 1996-08-14
Granted: 2000-08-15
Abstract: Compensation method is one in which the pressure in two adjustment cylinders for the determination of the rolling forces on one side of the roller gap, and the indicated forces of the force measuring devices to determine the rolling forces on the opposite side of the roller gap are co-ordinated. By including the working roller axial forces determinable by the pressure in the displacement cylinders of the working rollers, the total axial forces (T) in the plant can be determined by calculation during the operation of the rollers.
Patent AT-E176248-T1 (AT)
Inventor: PO RICCARDO
IPC: C08F2/02
Filed: 1996-11-12
Granted: 1999-02-15
Abstract: Process for the preparation of crystalline vinylaromatic polymers with a predominantly syndiotactic structure which comprises polymerizing vinylaromatic monomers, alone or mixed with at least one other monomer, in the presence of a catalytic system essentially consisting of:   a) a complex of titanium or zirconium selected from those having general formula: MR1R2R3R4, A1MR1R2R3, A1A2MR1R2 b) a co-catalyst selected from an alkylalumoxane and a compound of boron having formula (II): BX1X2X3 or one of its salts; c) a derivative of tin having general formula: SnR5R6R7R8
Patent AT-E200562-T1 (AT)
Inventor: WESTHOFF WILLIAM L
IPC: F16G1/28
Filed: 1996-09-27
Granted: 2001-04-15
Abstract: A power transmission belt (12) with a body of belt material and belt teeth (20) formed of the body and covered with a knitted fabric (24) with a 1 x 1 rib construction. <IMAGE>   <IMAGE>
Patent AT-E228540-T1 (AT)
Inventor: JOST PHILIPPE
IPC: C07C69/65
Filed: 1996-07-25
Granted: 2002-12-15
Abstract: Halogenated pref. fluorinated polyorganosiloxanes (POS) have the formula Ä(R<1>)a(Gf)b(E)pSiO1/2Ü-ÄR<2>GfSiO2/2Üz-ÄR<2>ESiO2/2 Üe-ÄHR<2>SiO2/2Üy1-Ä(R<2>)2-SiO2/2Üy-Ä(R<1>)a</S B>(Gf)b(E)p-SiO1/2Ü (I) and (II). In the formulae, (i) a + b + p = 3; a = 2, 3; b, p = 0, 1; z = 0- 200 (1-90); y1 = 0-10 (0-5); y = 0-50 (0-25); and e = 1-200 (1-90); with the conditions if z is not 0 then y + y1 + e =5-200 (10-100) and (z/(z + y + y1 + e + 2) x 100 ≥ 3 (pref. ≥ 5); if z = 0 then y=y1 +e = 5-50 and b > 0 in at least one alkoxy group; if e > 0 then z + y1 + y + e = 5-200 (pref. 10-100) and (z/(z + y + y1 + e + 2)) x 100 ≥ 3 (pref. ≥ 5); and if e = 0 then y + y1 + z = 5-100 and p > 0 in at least one group; (ii) z' = 1-9 (1-4.5); (iii) y1' = 0-0.5 (0.25); (iv) y' = 0-5 (0.5); (v) R1-2 = 1-12C (1-6C) aryl, aralkyl, alkylaryl (opt. branched); (vi) (Gf) = -(Z1)h-(Z2)g-Ä(Z3)j-RfÜk with h = 0.1;g = 0.1; j = 0.1; and k = 1 or 2; at least one Gf group is present in POS pref. 60% per mol.; Z1 = (CmH2m) with m ≥ 2 and, if m = 2 then g > 0 in at least one Gf; Z2 = -W(-C(O)-)2, -CRa(-C(O)-)2, -W(OH)-, -ÄW-NH-COÜ-, -ÄW-C(O)-Ü-, -Si(R<6>)<, or gp. (x) or (y); Ra or R<6> = H or 1-6C alkyl; in each case, one free valency is attached to Rf and the other to hydroxyl or 1-6C alkoxy; W = cyclic or non-cyclic hydrocarbon radical pref. aliphatic, alkenyl or aromatic; Z3 = with n ≥ 1, U = S, NH, NHSO, and pref. O; and Rf = -CqF2q-CF3, q ≥ 0, or -CqF2q-H, q ≥ 1, or -NRrfSO2CqF2q-CF3, q ≥ 0, Rrf = H, aryl, 1-6C alkyl; or -NRrfSO2CqF2q-H, q ≥ 1; and (vii) E is a monofunctional group chosen from e.g. amine alkoxyl, acyl, acyloxy, hydroxy, trialkoxysilyl, amide, ester, phenyl, arylalkoxy, aryloxy or ether-hydroxy.
Patent AT-E268536-T1 (AT)
Inventor: DURCHMAN ELINA
IPC: H04W88/10
Filed: 1996-01-11
Granted: 2004-06-15
Abstract: In mobile radio systems, it may be necessary to support multiple radio interfaces within a single mobile radio network. To support these multiple radio interfaces, it may be necessary to support even multiple signalling protocols within a single interface between a base station controller and a mobile switch, when base stations supporting different radio interfaces are connected via a common base station controller to the mobile switch. The mobile switch and the base station controller must be capable of recognizing to which signalling protocol a message transfer in the single interface belongs to. The messages transferred in the single interface are provided with a discrimination parameter which can be used to discriminate between the messages belonging to different radio interfaces and signalling protocols.
Patent AT-E187422-T1 (AT)
Inventor: BURGAARD CHRESTEN
IPC: C01G49/06
Filed: 1996-03-22
Granted: 1999-12-15
Abstract: A method of treating ferric oxide and/or ferric hydroxyde hydrate containing flux liquid slurry or flux liquid slurry filter cakes originating from a hot zincing process allows simple and economically advantageous disposal of such flux liquid slurry or flux liquid slurry filter cakes by heating thereof, optionally after dilution with water or flux liquid, to form crystals of alpha-hematite hydrate which are then separated.
Patent AT-E204923-T1 (AT)
Inventor: SCHAFFER GRAHAM BARRY
IPC: B22F1/00
Filed: 1996-05-02
Granted: 2001-09-15
Abstract: PCT No. PCT/AU96/00256 Sec. 371 Date Oct. 31, 1997 Sec. 102(e) Date Oct. 31, 1997 PCT Filed May 2, 1996 PCT Pub. No. WO96/34991 PCT Pub. Date Nov. 7, 1996The invention relates to an aluminum powder blend and sintered components produced from the aluminum powder blend. The powder is based on the precipitation hardenable 7000 series Al-Zn-Mg-Cu alloys with trace addition of lead or tin. The powder blend comprises 2-12 wt. % zinc, 1-5 wt. % magnesium, 0.1-5.6 wt. % copper, 0.01-0.3 wt. % lead or tin, and the balance aluminum. The invention also provides a composite powder comprising the foregoing powder blend and a reinforcing element or compound.
Patent AT-E191466-T1 (AT)
Inventor: CHEMBURKAR SANJAY R
IPC: C07C275/64
Filed: 1996-08-27
Granted: 2000-04-15
Abstract: The present invention provides a process for the preparation of a compound of formula   <IMAGE>   wherein R is a straight or branched alkyl group of from one to twelve carbon atoms; M represents hydrogen or a pharmaceutically acceptable cation; and A is selected from optionally substituted carbocyclic phenyl.
Patent AT-E323716-T1 (AT)
Inventor: LYTTLE MATTHEW H
IPC: A61K38/00
Filed: 1996-12-20
Granted: 2006-05-15
Abstract: Compounds wherein a biologically active molecule is coupled to a glutathione analog through a conjugated system which permits activation of the biologically active molecule while retaining the biologically active molecule tethered to the glutathione analog are useful as tethered prodrugs that slow the rate of clearance of an active biomolecule through the multidrug resistance pump.
Patent AT-E194805-T1 (AT)
Inventor: BIANCHI FILIPPO
IPC: B65D5/36
Filed: 1994-11-25
Granted: 2000-08-15
Abstract: The punched cardboard box is of the type delivered to the customers in a flattened condition and has a pair of opposite walls (A) already formed and a pair of opposite walls (B) to be formed connected to the walls (A) already formed by means of bellows tabs (29) foldable along an oblique folding line (12). The bellows tabs (29) have the function to produce the erection of the walls (A) already formed during the assembly of the box for obtaining a use configuration thereof. Each of said bellows tabs (29) has a tongue (30) projecting in the direction of the walls (B) to be formed and intended to be inwardly folded and to be glued against the end portions of the inner surface (19) of the adjacent wall (B) to be formed, so as to avoid the socalled "bag-effect" impairing the aesthetical appearance of the box, to resist to the lifting action exerted on the walls to be formed during the erection of the box, and to eliminate the differences in thickness during the glueing of the box in a flattened condition. <IMAGE>
Patent AT-E216480-T1 (AT)
Inventor: WALDNER HELMUTH
IPC: E04F19/04
Filed: 1997-08-08
Granted: 2002-05-15
Abstract: The device consists of a convector and a cover profile attached to the wall via a holder (4). The holder has a flange in the upper region for snap fitting of a tapping profile (6). The holder has a suspension flange (4a) and an attachment flange (4b) for the cover profile. There is at least one clip (4c) between the flanges for snap fitting a convector. Plug-in or snap-in connections (4d) are arranged in the lower region for the attachment of at least one installation channel (13) for mains current, telephones and/or antennas.
Patent AT-E253110-T1 (AT)
Inventor: PAPADOPOULOU BARBARA
IPC: A61K39/008
Filed: 1997-05-06
Granted: 2003-11-15
Abstract: Attenuated strains of Leishmania are provided in which at least one gene contributing to virulence of the strain and expressed in both the promastigote and amastigote forms of the strain is functionally disabled, such as, by deleting at least a portion of the gene or by mutagenesis of the gene. The attenuated strain may be used for administration to a host to confer protection against disease caused by a virulent Leishmania strain or as a diagnostic reagent.
Patent AT-E215683-T1 (AT)
Inventor: MAYENCON ROLAND
IPC: A62C2/12
Filed: 1997-06-24
Granted: 2002-04-15
Abstract: A shutter consists of a plate (4) which pivots inside a surround (2). The plate is made from two identical halves (4a, 4b), fitted together face to face with overlapping edges, and its surround is made from two rectangular members, each having a thickness equivalent to half the plate and joined together to form stops for the plate edges. In a variant of the design the plate and surround can be circular in shape. The plate has spindles it diametrically-opposite edges which engage with matching holes in the surround and allow the shutter to turn about a central pivot for opening and closing. Seals can be included to make the shutter airtight.
Patent AT-E211789-T1 (AT)
Inventor: PICHLER ALOIS
IPC: E02D29/14
Filed: 1997-08-28
Granted: 2002-01-15
Abstract: The cover has an insert (4) with a top flange for a lid (1), and a ring-shaped part (6), fastened to elements (5) on the lid. The flange has the same shape as the top shaft end. The tubular insert projects into the shaft (2). For height-adjustment, the cover part is fastened to the elements on the lid at the correct height, and is then placed on the top shaft end. The elements on the lid are formed by mainly horizontal ribs, and correspondingly shaped grooves (7) on the ring-shaped part engage over the ribs.
Patent AT-E466862-T1 (AT)
Inventor: MACH ROBERT
IPC: C07D451/04
Filed: 1997-03-19
Granted: 2010-05-15
Abstract: PCT No. PCT/US97/04403 Sec. 371 Date Sep. 17, 1998 Sec. 102(e) Date Sep. 17, 1998 PCT Filed Mar. 19, 1997 PCT Pub. No. WO97/34892 PCT Pub. Date Sep. 25, 1997The invention provides detectably-labeled compounds of formula (I): wherein A, B, C, D, E, F, R, X, Y and Z have any of the meanings given in the specification, and their pharmaceutically acceptable salts, are useful in competitive assays to assay for the presence of  sigma 2 receptors. Also disclosed are pharmaceutical compositions containing such a compound of formula (I), methods for their use and intermediates useful for preparing such compounds of formula (I).
Patent AT-E217832-T1 (AT)
Inventor: PREVOTAT BERNARD
IPC: B29B13/04
Filed: 1997-09-18
Granted: 2002-06-15
Abstract: The invention concerns a method for treating plastic tubes, in particular PCV tubes, obtained by extrusion, whereby a tube is brought to a molecular orientation temperature, higher than room temperature, and is subjected to bi-axial drawing by radial expansion and axial elongation, to obtain a bi-oriented tube whose mechanical properties are improved. The tube (T) is cut into elements (4) of predetermined length immediately after being extruded and its temperature is higher than the molecular orientation temperature, each element constituting a blank (5); each blank (5) is placed in a chamber (E) to be cooled therein by a fluid (F) to a temperature close to the molecular orientation temperature, the dwell time of the blank in the chamber being greater than the time of its production by extrusion; and the blank (5) is then extracted from the chamber (E) to be subjected to a treatment enabling its bi-orientation.
Patent AT-E207874-T1 (AT)
Inventor: WHEELER CARL J
IPC: C12N15/09
Filed: 1997-04-08
Granted: 2001-11-15
Abstract: Cationic lipids, having a derivatized quaternary ammonium head group, that provide improved cell targeting ability and enhanced transfective efficacy for the delivery of molecules into cells. The lipids comprise a linker having functional groups that provide sites for further attachment of drugs, cell receptor ligands or other bioactive agents.
Patent AT-E261974-T1 (AT)
Inventor: HAUSHEER FREDERICK HERMAN
IPC: A61K31/4745
Filed: 1997-08-15
Granted: 2004-04-15
Abstract: Novel compounds, formulations and methods of treating patients with cancer are provided for in this invention. The compounds are derivatives of camptothecin, and specifically relate to compounds having novel substitutions at the C-7 position of the camptothecin scaffold B-ring. The formula I compounds are highly lipophilic, lactone stable, do not require metabolic activation, and are potent antineoplastic compounds.
Patent AT-E209201-T1 (AT)
Inventor: TAVERAS ARTHUR G
IPC: A61K31/4545
Filed: 1997-09-11
Granted: 2001-12-15
Abstract: Novel compounds of formula (1.0) are disclosed. Compounds of formula (1.0) are represented by the compounds of formulas (1.4) or (1.5) wherein R<1>, R<3> and R<4> are each independently selected from halo. W represents a group selected from (a), (b), (c) or (d). Also disclosed are methods of inhibiting farnesyl protein transferase and the growth of abnormal cells, such as tumor cells.